Crinetics Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CEOScott R. Struthers
CEOScott R. Struthers
Employees290
Employees290
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2008
Founded2008
Employees290
Employees290
CRNX Key Statistics
Market cap3.28B
Market cap3.28B
Price-Earnings ratio-11.39
Price-Earnings ratio-11.39
Dividend yield—
Dividend yield—
Average volume540.23K
Average volume540.23K
High today$42.87
High today$42.87
Low today$41.67
Low today$41.67
Open price$42.49
Open price$42.49
Volume563.21K
Volume563.21K
52 Week high$49.58
52 Week high$49.58
52 Week low$15.76
52 Week low$15.76
CRNX News
Simply Wall St 2d
Investors in Crinetics Pharmaceuticals have seen stellar returns of 142% over the past three years - Simply Wall StIt might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But in contrast you can make much...
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%